| 摘要 |
Compounds according to Formula I are potent inhibitors of Arginase I and II activity:
where R 1 , R 2 , R 3 , R 4 , D, W, X, Y, and Z are defined in the specification. The invention also provides pharmaceutical compositions of the compounds and methods of their use in treating or preventing a disease or a condition associated with arginase activity. |
